TG Therapeutics, Inc. (TGTX) Misses Q1 EPS by 6c

TG Therapeutics, Inc. (NASDAQ: TGTX) reported Q1 EPS of ($0.25), $0.06 worse than the analyst estimate of ($0.19).TG Therapeutics, Inc. reaffirmed FY2014 guidance.

For earnings history and earnings-related data on TG Therapeutics, Inc. (TGTX) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Yalla Group Limited (YALA) Reports Q2 EPS of $0.24
• XP Inc. (XP) Tops Q2 EPS by 8c